Skip to main content
SpringerLink
Log in

Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province

  • Original Research Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Arylesterase activity of Paraoxonase-1 (PON1) enzyme may be play important role in initiation and progression of several diseases. Activity or serum level of Arylesterase can be affected by many genetic alterations such as SNPs. The reduction in the activity and serum level of Arylesterase could be involved in Type2 diabetes mellitus (T2DM). The aim of this investigation is to examine the association between Arylesterase activity and promoter polymorphism (− 108C > T) of PON1gene in patients with T2DM in Golestan Province, northern area of Iran. Achievement of this purpose was due to DNA obtaining from blood then SNP determination using PCR–RFLP and Arylesterase activity measurement in the serum of 90 normal individuals and 90patients suffering diabetes. Data was processed by SPSS software version 16. The significant association was observed between the Arylesterase activity and three genotypes of PON1 gene such as CC, CT, and TT in subjects with T2DM. In the present study, it has been shown level of Arylestrase activity of PON1 in patients (117.33 ± 63.96) is lower than it in control group (289.33 ± 68.38); P < 0.05. Our results declared that activity of Arylesterase in diabetic patients was significantly lower than the healthy individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–30.

    Article  CAS  Google Scholar 

  2. Andreassi MG. Metabolic syndrome, diabetes and atherosclerosis: influence of gene–environment interaction. Mutat Res/Fundam Mol Mech Mutagen. 2009;667(1–2):35–43.

    Article  CAS  Google Scholar 

  3. Rani J, Mittal I, Pramanik A, Singh N, Dube N, Sharma S, et al. T2DiACoD: a gene atlas of type 2 diabetes mellitus associated complex disorders. Sci Rep. 2017;7(1):1–21.

    Article  CAS  Google Scholar 

  4. Kordonouri O, Danne TH, Hopfenmuller W. Lipid profiles and blood pressure: are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin dependent diabetes mellitus? Acta Paediatr. 1996;85:43–8.

    Article  CAS  Google Scholar 

  5. Furlong CE, Li WF, Brophy VH, Jarvik GP, Richter RJ, Shih DM, et al. The PON 1 gene and detoxication. Neurotoxicology. 2000;21:581–7.

    CAS  PubMed  Google Scholar 

  6. Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, et al. Human serum paraoxonase (PON 1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos. 2000;28:1335–42.

    CAS  PubMed  Google Scholar 

  7. Ferre N, Tous M, Paul A, Zamora A, Vendrell JJ, Bardaji A, et al. araoxonase Gln–Arg(192) and Leu-Met (55) gene polymorphisms and enzyme activity ina population with a low rate of coronary heart disease. Clin Biochem. 2002;35:197–203.

    Article  CAS  Google Scholar 

  8. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med. 2005;38:153–63.

    Article  CAS  Google Scholar 

  9. Gowda V, Kusuma K, Vasudha K. Serum paraoxonase (Arylesterase) activity in Type 2Diabetes mellitus and diabetic nephropathy. Med Sci. 2013;3:229–555X.

    Google Scholar 

  10. Khersonsky O, Roodveldt C, Tawfik DS. Enzyme promiscuity: evolutionary and mechanistic aspects. Curr Opin Chem Biol. 2006;10:498–508.

    Article  CAS  Google Scholar 

  11. Qing-Yang H, Meng-Rong E, Sen-Lin J. Linkage and association studies of the susceptibility genes for type 2 diabetes. Actu Genet Sin. 2006;33:573–89.

    Article  Google Scholar 

  12. Wang M, Lang X, Zou L, Huang S, Xu Z. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case–control studies. Atherosclerosis. 2011;214(2):377–85.

    Article  CAS  Google Scholar 

  13. Karabina SA, Lehner AN, Frank E, Parthasarathy S, Santanam N. Oxidative inactivation of paraoxonase—implications in diabetes mellitus and atherosclerosis. Biochim Biophys Acta. 2005;1725:213–21.

    Article  CAS  Google Scholar 

  14. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 1991;86:193–9.

    Article  CAS  Google Scholar 

  15. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and it, s relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol. 1995;15:1812–8.

    Article  CAS  Google Scholar 

  16. Altuner D, Suzen SH, Ates I, Koc GV, Aral Y. Are PON1 Q/R 192 and M/L55 polymorphisms risk factors for diabetes complications in Turkish population? Clin Biochem. 2011;44:372–6.

    Article  CAS  Google Scholar 

  17. Ergun MA, Yurtcu E, Demirci H, Ilhan MN, Barkar V. PON1 55 and 192 gene polymorphisms in type 2 diabetes mellitus patients in a Turkish population. Biochem Genet. 2011;49:1–8.

    Article  CAS  Google Scholar 

  18. Gupta N, Binukumar B, Singh S, Sunkaria A, Kandimalla R, Bhansali A. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gene. 2011;487:88–95.

    Article  CAS  Google Scholar 

  19. Shakeri R, Marjani A, Khajeniazi S. Association between promoter polymorphism (− 108C > T) of paraoxonase1 gene and it’s paraoxonase activity in patients with Type2 diabetes in northern Iran. Clin Chim Acta. 2017;474:34–7.

    Article  CAS  Google Scholar 

  20. Furlnog CE, Richter RJ, Seidel SL, Motulsky AG. Role of genetic polymorphism of human plasma paraoxonasel arylesterase in hydrolysis of the insecticide metabolites chloropyrifos oxan and paraoxon. Am J Hum Genet. 1988;43:230–8.

    Google Scholar 

  21. Samadi A, Alvani SM, Ghazi-khosai M. Paraoxonase and arylesterase activity among hypercholesrerolemic patients. Med J Duma Theislamic Repub Iran. 2003;17(1):67–73.

    Google Scholar 

  22. Jureti D, Motejlkova A, Kunovi B, Reki B, Flegar Z. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus. Acta Pharm. 2006;56:59–68.

    Google Scholar 

  23. Tabur S, Torun A, Sabuncu T, Nuri Turan M, Celik H, Ocak A. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation. Eur J Endocrinol. 2010;162:535–41.

    Article  CAS  Google Scholar 

  24. Wegner M, Pioruńska Stolzmann M, Araszkiewicz M, Zozulińska Ziołkiewicz D, Wierusz Wysocka B. Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes. Pol Arch Med Wewn. 2011;121:448–55.

    CAS  PubMed  Google Scholar 

  25. Wilson Tang W, Hartiala J, Fan Y, Wu Y, Stewart A, Erdmann J, et al. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2012;32:2803–12.

    Article  Google Scholar 

  26. Małgorzata Ewa Bednarska-Makaruk M, Krzywkowski M, Graban A, Lipczyńska-Łojkowska W, Bochyńska A, Rodo M, et al. Paraoxonase 1 (PON1) gene − 108C > T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia. Folia Neuropathol. 2013;51:111–9.

    Article  Google Scholar 

  27. Hampe M, Mogarekar M. Paraoxonase1 activity, its Q192R polymorphism and diabetic retinopathy in type 2 diabetes mellitus. Int J Biomed Adv Res. 2014;5:35–40.

    Article  CAS  Google Scholar 

  28. Eren E, Abuhandan M, Solmaz A, Taşkın A. Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome. J Clin Res Pediatr Endocrinol. 2014;6:163–8.

    Article  Google Scholar 

  29. Shakeri R, Marjani A, Khajeniazi S, Kaviani MR. Paraoxonase and arylesterase activities in serum of patients with alzheimer disease in Gorgan, North East of Iran. Transylv Rev. 2016;XXIV:2820–7.

    Google Scholar 

Download references

Acknowledgements

The authors would like to appreciate from Dr Mohammad Mojerloo, internal medicine, who help us in sampling process in this study. This project has been registered in Golestan University of Medical Sciences (Gorgan, Iran) under approval number of 940805194 and Ethical Code goums.rec.1394.76 and funded by the “Deputy of Research and Technology” of the university.

Author information

Authors and Affiliations

  1. Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran

    Safoura Khajeniazi

  2. Department of Biochemistry and Biophysics, Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran

    Raheleh Shakeri & Abdoljalal Marjani

Authors
  1. Safoura Khajeniazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raheleh Shakeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abdoljalal Marjani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Safoura Khajeniazi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khajeniazi, S., Shakeri, R. & Marjani, A. Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province. Ind J Clin Biochem 35, 239–244 (2020). https://doi.org/10.1007/s12291-019-00822-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-019-00822-3

Keywords

Search

Navigation